Responsibilities include• Broad remit across life science tools, CROs, healthcare data solutions and software, drug development, medical devices and diagnostics• Healthcare coverage for the global Amati Strategic Innovation Fund o Launched the fund in May 2022 as a team of three. o Worked collaboratively to refine strategy, processes, portfolio construction. o Marketed the fund to potential investors and journalists. o Actively involved in all aspects of portfolio management• Healthcare coverage for UK focused Smaller Companies Fund, AIM Venture Capital Trust and the Amati IHT Portfolio Service• Broadening coverage to include tech and gaming • Passed CFA Level 1 (May 2023)

• Working with early stage biotech & life science companies, specialising in o Operational and strategic issues o Technical due diligence o Experiment design o IP development and troubleshooting o Grant writing o Fund raising

Embedded in the CMVM, University of Edinburgh, I am part of a specialist life science/ healthcare commercialisation team for one of the top rated medical and vet schools in the UK. Responsibilities include:• Conducting strategic analysis, market opportunity assessments and due diligence of innovations to identify the highest value opportunities and create the most compelling investment story• Undertaking project management & operational support of a portfolio of therapeutic, medical device and diagnostic innovations as they are developed towards commercialisation• Formulating and implementing strategies for effective commercialisation of IP• Identifying and applying for translational research funding• Preparing compelling communication materials for, and pitching opportunities to, investors and corporates• Business development and relationship management internally with leading academics, and externally with investors, pharma & biotech companies, incubators, funders and government agencies

PharmaVentures has a successful track record in transaction outcomes in both M&A and Licensing. Our expertise brings a unique strategic and commercial insight within healthcare. This makes us ideally placed to support your business from strategic development, through to valuation/deal terms and, ultimately, to getting the deal done.As an Analyst I have worked on a range of Consultancy and Advisory projects for UK, EU, USA and Australasian healthcare companies, including: Business Development & Licensing Bench marking Expert Reports Due Diligence ValuationFor the successful delivery of these projects I have used: EvaluatePharma RecapIQ Cortellis CapitalIQAs well as writing presentations and IMs, managing client meetings and expectations, negotiating CDAs on behalf of clients, updating clients on key deliverables & project progress and contacting targets to discuss potential licensing opportunities.

White Space is a leading market analysis and strategy consultancy. We help clients make big decisions to enter new markets, re-energise existing markets, develop new propositions and optimise customer operations. Based in central Oxford, we work for blue chip clients worldwide.We believe there is no substitute for the right information. Therefore our recommendations are based on a bedrock of bespoke primary data collection and proprietary analysis methodologies.Our clients include EDF, Gap, Lloyds Banking Group, BSkyB, Carphone Warehouse and MITIE.Expertise: o Commercial Performance Analysiso Market Assessmento New Growth Identificationo Proposition Developmento Customer Operations Improvement

Conduct research to produce detailed company profiles, covering products, services, corporate finance news and management

DPhil Systems Biology DTC - BiochemistryTitle: Re-engineering Bacterial Two Component Signalling SystemsOverview: Designed chimeric proteins to create a synthetic two component system. Tested their binding, phosphorylation and DNA binding in vitro with SPR, radioactive phosphotransfer and fluorescent anisotropy